Moberg licenses OTC Nalox drug to Meda
Moberg Derma has given marketing license for its over-the-counter (OTC) Nalox to Meda as a treatment for discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis.
The new deal covers several major European countries, such as Germany, France, the UK, Spain, Austria, the Netherlands and Belgium.
Under the deal, Meda is responsible to pay a sum of SEK 32m, with SEK13m when signing the contract and the remaining SEK19m in future milestone payments to Moberg.
Moberg CEO Peter Wolpert said this agreement is a key step in the global launch of Nalox.
Related Insight
Suppliers Directory
Echo Pharmaceuticals - Advanced Technology Platform for Drug Delivery Systems, Formulation and Isolation
Echo Pharmaceuticals is a technology-based pharmaceutical drug development company, with a patented drug delivery technology, Alitra™, to formulate lipophilic active drug candidates into optimal delivery systems and innovative medicines suitable for clinical trials.
Production & Manufacturing > OTC > Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
OTC Intelligence
Analytical Cannabinoid Standards
Published by Echo Pharmaceuticals
Production & Manufacturing > OTC > White Papers
Sterilisation Technologies Today and Tomorrow Building and Maintaining Sterility Assurance
Published by Parenteral Drug Association (PDA)
Production & Manufacturing > OTC > White Papers
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations Buy online from $200
API research into pharmaceutical companies and corporations Buy online from $200
Comments may be moderated for spam, obscenities or defamation.